Henry O. Gosebruch, EVP, Chief Strategy Officer at AbbVie Inc. (ABBV), sold 45,156 shares at $147.54 ($6.7M) on 2022-03-01, disclosed to the SEC on 2022-03-01.
Scheduled sale ($6.7M) by EVP, Chief Strategy Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $149.54 | 30,156 | $4.5M | 67.0% |
| 2 | $147.54 | 5,596 | $826K | 12.3% |
| 3 | $148.62 | 8,303 | $1.2M | 18.3% |
| 4 | $149.14 | 1,101 | $164K | 2.4% |
| Total | $149.11 avg | 45,156 | $6.7M | 100% |
| Filing → |
| ABBV | SELL | 2022-05-20 | $13.0M | — | Filing → |
| ABBV | SELL | 2022-03-02 | $6.8M | — | Filing → |
| ABBV | SELL | 2020-11-24 | $4.0M | — | Filing → |